 | • レポートコード：GIR-105X14338 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腎性貧血治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腎性貧血治療の種類別市場規模（鉄分サプリメント、赤血球刺激剤）、用途別市場規模（病院、薬局、研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腎性貧血治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen Inc.、F. Hoffmann-La Roche Ltd、Pfizer Inc.、Novartis AG、Johnson & Johnson Services Inc.、Teva Pharmaceutical Industries Ltd.、AMAG Pharmaceuticals、Rockwell Medical、Akebia Therapeutics、Vifor Pharma Management Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：鉄分サプリメント、赤血球刺激剤 ・用途別分析2016年-2026年：病院、薬局、研究機関、その他 ・腎性貧血治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腎性貧血治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腎性貧血治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腎性貧血治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腎性貧血治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Renal Anemia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Renal Anemia Treatment size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Renal Anemia Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Renal Anemia Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Iron Supplements
Erythrocyte Stimulating Agents
Market segment by Application can be divided into
Hospital
Pharmacy
Research Institute
Other
The key market players for global Renal Anemia Treatment market are listed below:
Amgen Inc.
F. Hoffmann-La Roche Ltd
Pfizer Inc.
Novartis AG
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
AMAG Pharmaceuticals
Rockwell Medical
Akebia Therapeutics
Vifor Pharma Management Ltd.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Renal Anemia Treatment Introduction
1.2 Market Analysis
1.2.1 Overview: Global Renal Anemia Treatment Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Iron Supplements
1.2.3 Erythrocyte Stimulating Agents
1.3 Market Analysis
1.3.1 Overview: Global Renal Anemia Treatment Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Research Institute
1.3.5 Other
1.4 Global Renal Anemia Treatment Market Size & Forecast
1.4.1 Global Renal Anemia Treatment Sales in Value (2016-2026))
1.4.2 Global Renal Anemia Treatment Sales in Volume (2016-2026)
1.4.3 Global Renal Anemia Treatment Price by Type (2016-2026) & (USD/MT)
1.5 Global Renal Anemia Treatment Production Capacity Analysis
1.5.1 Global Renal Anemia Treatment Total Production Capacity (2016-2026)
1.5.2 Global Renal Anemia Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Renal Anemia Treatment Market Drivers
1.6.2 Renal Anemia Treatment Market Restraints
1.6.3 Renal Anemia Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Amgen Inc.
2.1.1 Amgen Inc. Details
2.1.2 Amgen Inc. Major Business
2.1.3 Amgen Inc. Renal Anemia Treatment Product and Services
2.1.4 Amgen Inc. Renal Anemia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 F. Hoffmann-La Roche Ltd
2.2.1 F. Hoffmann-La Roche Ltd Details
2.2.2 F. Hoffmann-La Roche Ltd Major Business
2.2.3 F. Hoffmann-La Roche Ltd Renal Anemia Treatment Product and Services
2.2.4 F. Hoffmann-La Roche Ltd Renal Anemia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer Inc.
2.3.1 Pfizer Inc. Details
2.3.2 Pfizer Inc. Major Business
2.3.3 Pfizer Inc. Renal Anemia Treatment Product and Services
2.3.4 Pfizer Inc. Renal Anemia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Renal Anemia Treatment Product and Services
2.4.4 Novartis AG Renal Anemia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Johnson & Johnson Services Inc.
2.5.1 Johnson & Johnson Services Inc. Details
2.5.2 Johnson & Johnson Services Inc. Major Business
2.5.3 Johnson & Johnson Services Inc. Renal Anemia Treatment Product and Services
2.5.4 Johnson & Johnson Services Inc. Renal Anemia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Teva Pharmaceutical Industries Ltd. Details
2.6.2 Teva Pharmaceutical Industries Ltd. Major Business
2.6.3 Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Product and Services
2.6.4 Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 AMAG Pharmaceuticals
2.7.1 AMAG Pharmaceuticals Details
2.7.2 AMAG Pharmaceuticals Major Business
2.7.3 AMAG Pharmaceuticals Renal Anemia Treatment Product and Services
2.7.4 AMAG Pharmaceuticals Renal Anemia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Rockwell Medical
2.8.1 Rockwell Medical Details
2.8.2 Rockwell Medical Major Business
2.8.3 Rockwell Medical Renal Anemia Treatment Product and Services
2.8.4 Rockwell Medical Renal Anemia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Akebia Therapeutics
2.9.1 Akebia Therapeutics Details
2.9.2 Akebia Therapeutics Major Business
2.9.3 Akebia Therapeutics Renal Anemia Treatment Product and Services
2.9.4 Akebia Therapeutics Renal Anemia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Vifor Pharma Management Ltd.
2.10.1 Vifor Pharma Management Ltd. Details
2.10.2 Vifor Pharma Management Ltd. Major Business
2.10.3 Vifor Pharma Management Ltd. Renal Anemia Treatment Product and Services
2.10.4 Vifor Pharma Management Ltd. Renal Anemia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Renal Anemia Treatment Sales by Manufacturer
3.1 Global Renal Anemia Treatment Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Renal Anemia Treatment Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Renal Anemia Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Renal Anemia Treatment Manufacturer Market Share
3.4.2 Top 6 Renal Anemia Treatment Manufacturer Market Share
3.5 Global Renal Anemia Treatment Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Renal Anemia Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Renal Anemia Treatment Market Size by Region
4.1.1 Global Renal Anemia Treatment Sales in Volume by Region (2016-2026)
4.1.2 Global Renal Anemia Treatment Revenue by Region (2016-2026)
4.2 North America Renal Anemia Treatment Revenue (2016-2026)
4.3 Europe Renal Anemia Treatment Revenue (2016-2026)
4.4 Asia-Pacific Renal Anemia Treatment Revenue (2016-2026)
4.5 South America Renal Anemia Treatment Revenue (2016-2026)
4.6 Middle East and Africa Renal Anemia Treatment Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Renal Anemia Treatment Sales in Volume by Type (2016-2026)
5.2 Global Renal Anemia Treatment Revenue by Type (2016-2026)
5.3 Global Renal Anemia Treatment Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Renal Anemia Treatment Sales in Volume by Application (2016-2026)
6.2 Global Renal Anemia Treatment Revenue by Application (2016-2026)
6.3 Global Renal Anemia Treatment Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Renal Anemia Treatment Sales by Type (2016-2026)
7.2 North America Renal Anemia Treatment Sales by Application (2016-2026)
7.3 North America Renal Anemia Treatment Market Size by Country
7.3.1 North America Renal Anemia Treatment Sales in Volume by Country (2016-2026)
7.3.2 North America Renal Anemia Treatment Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Renal Anemia Treatment Sales by Type (2016-2026)
8.2 Europe Renal Anemia Treatment Sales by Application (2016-2026)
8.3 Europe Renal Anemia Treatment Market Size by Country
8.3.1 Europe Renal Anemia Treatment Sales in Volume by Country (2016-2026)
8.3.2 Europe Renal Anemia Treatment Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Renal Anemia Treatment Sales by Type (2016-2026)
9.2 Asia-Pacific Renal Anemia Treatment Sales by Application (2016-2026)
9.3 Asia-Pacific Renal Anemia Treatment Market Size by Region
9.3.1 Asia-Pacific Renal Anemia Treatment Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Renal Anemia Treatment Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Renal Anemia Treatment Sales by Type (2016-2026)
10.2 South America Renal Anemia Treatment Sales by Application (2016-2026)
10.3 South America Renal Anemia Treatment Market Size by Country
10.3.1 South America Renal Anemia Treatment Sales in Volume by Country (2016-2026)
10.3.2 South America Renal Anemia Treatment Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Renal Anemia Treatment Sales by Type (2016-2026)
11.2 Middle East & Africa Renal Anemia Treatment Sales by Application (2016-2026)
11.3 Middle East & Africa Renal Anemia Treatment Market Size by Country
11.3.1 Middle East & Africa Renal Anemia Treatment Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Renal Anemia Treatment Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Renal Anemia Treatment Typical Distributors
12.3 Renal Anemia Treatment Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Renal Anemia Treatment Revenue by Type, (USD Million), 2021-2026
Table 2. Global Renal Anemia Treatment Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Inc. Major Business
Table 5. Amgen Inc. Renal Anemia Treatment Product and Services
Table 6. Amgen Inc. Renal Anemia Treatment Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 8. F. Hoffmann-La Roche Ltd Major Business
Table 9. F. Hoffmann-La Roche Ltd Renal Anemia Treatment Product and Services
Table 10. F. Hoffmann-La Roche Ltd Renal Anemia Treatment Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Inc. Major Business
Table 13. Pfizer Inc. Renal Anemia Treatment Product and Services
Table 14. Pfizer Inc. Renal Anemia Treatment Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 16. Novartis AG Major Business
Table 17. Novartis AG Renal Anemia Treatment Product and Services
Table 18. Novartis AG Renal Anemia Treatment Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Johnson & Johnson Services Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Services Inc. Major Business
Table 21. Johnson & Johnson Services Inc. Renal Anemia Treatment Product and Services
Table 22. Johnson & Johnson Services Inc. Renal Anemia Treatment Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Ltd. Major Business
Table 25. Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Product and Services
Table 26. Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. AMAG Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. AMAG Pharmaceuticals Major Business
Table 29. AMAG Pharmaceuticals Renal Anemia Treatment Product and Services
Table 30. AMAG Pharmaceuticals Renal Anemia Treatment Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Rockwell Medical Basic Information, Manufacturing Base and Competitors
Table 32. Rockwell Medical Major Business
Table 33. Rockwell Medical Renal Anemia Treatment Product and Services
Table 34. Rockwell Medical Renal Anemia Treatment Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Akebia Therapeutics Basic Information, Manufacturing Base and Competitors
Table 36. Akebia Therapeutics Major Business
Table 37. Akebia Therapeutics Renal Anemia Treatment Product and Services
Table 38. Akebia Therapeutics Renal Anemia Treatment Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Vifor Pharma Management Ltd. Basic Information, Manufacturing Base and Competitors
Table 40. Vifor Pharma Management Ltd. Major Business
Table 41. Vifor Pharma Management Ltd. Renal Anemia Treatment Product and Services
Table 42. Vifor Pharma Management Ltd. Renal Anemia Treatment Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Renal Anemia Treatment Sales by Manufacturer (2019-2021e) & (MT)
Table 44. Global Renal Anemia Treatment Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Renal Anemia Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Renal Anemia Treatment Production Capacity by Company, (MT): 2020 VS 2021
Table 47. Head Office and Renal Anemia Treatment Production Site of Key Manufacturer
Table 48. Global Renal Anemia Treatment Sales by Region (2016-2021e) & (MT)
Table 49. Global Renal Anemia Treatment Sales by Region (2021-2026) & (MT)
Table 50. Global Renal Anemia Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Renal Anemia Treatment Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Renal Anemia Treatment Sales by Type (2016-2021e) & (MT)
Table 53. Global Renal Anemia Treatment Sales by Type (2021-2026) & (MT)
Table 54. Global Renal Anemia Treatment Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Renal Anemia Treatment Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Renal Anemia Treatment Price by Type (2016-2021e) & (USD/MT)
Table 57. Global Renal Anemia Treatment Price by Type (2021-2026) & (USD/MT)
Table 58. Global Renal Anemia Treatment Sales by Application (2016-2021e) & (MT)
Table 59. Global Renal Anemia Treatment Sales by Application (2021-2026) & (MT)
Table 60. Global Renal Anemia Treatment Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Renal Anemia Treatment Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Renal Anemia Treatment Price by Application (2016-2021e) & (USD/MT)
Table 63. Global Renal Anemia Treatment Price by Application (2021-2026) & (USD/MT)
Table 64. North America Renal Anemia Treatment Sales by Country (2016-2021e) & (MT)
Table 65. North America Renal Anemia Treatment Sales by Country (2021-2026) & (MT)
Table 66. North America Renal Anemia Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Renal Anemia Treatment Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Renal Anemia Treatment Sales by Type (2016-2021e) & (MT)
Table 69. North America Renal Anemia Treatment Sales by Type (2021-2026) & (MT)
Table 70. North America Renal Anemia Treatment Sales by Application (2016-2021e) & (MT)
Table 71. North America Renal Anemia Treatment Sales by Application (2021-2026) & (MT)
Table 72. Europe Renal Anemia Treatment Sales by Country (2016-2021e) & (MT)
Table 73. Europe Renal Anemia Treatment Sales by Country (2021-2026) & (MT)
Table 74. Europe Renal Anemia Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Renal Anemia Treatment Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Renal Anemia Treatment Sales by Type (2016-2021e) & (MT)
Table 77. Europe Renal Anemia Treatment Sales by Type (2021-2026) & (MT)
Table 78. Europe Renal Anemia Treatment Sales by Application (2016-2021e) & (MT)
Table 79. Europe Renal Anemia Treatment Sales by Application (2021-2026) & (MT)
Table 80. Asia-Pacific Renal Anemia Treatment Sales by Region (2016-2021e) & (MT)
Table 81. Asia-Pacific Renal Anemia Treatment Sales by Region (2021-2026) & (MT)
Table 82. Asia-Pacific Renal Anemia Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Renal Anemia Treatment Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Renal Anemia Treatment Sales by Type (2016-2021e) & (MT)
Table 85. Asia-Pacific Renal Anemia Treatment Sales by Type (2021-2026) & (MT)
Table 86. Asia-Pacific Renal Anemia Treatment Sales by Application (2016-2021e) & (MT)
Table 87. Asia-Pacific Renal Anemia Treatment Sales by Application (2021-2026) & (MT)
Table 88. South America Renal Anemia Treatment Sales by Country (2016-2021e) & (MT)
Table 89. South America Renal Anemia Treatment Sales by Country (2021-2026) & (MT)
Table 90. South America Renal Anemia Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Renal Anemia Treatment Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Renal Anemia Treatment Sales by Type (2016-2021e) & (MT)
Table 93. South America Renal Anemia Treatment Sales by Type (2021-2026) & (MT)
Table 94. South America Renal Anemia Treatment Sales by Application (2016-2021e) & (MT)
Table 95. South America Renal Anemia Treatment Sales by Application (2021-2026) & (MT)
Table 96. Middle East & Africa Renal Anemia Treatment Sales by Country (2016-2021e) & (MT)
Table 97. Middle East & Africa Renal Anemia Treatment Sales by Country (2021-2026) & (MT)
Table 98. Middle East & Africa Renal Anemia Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Renal Anemia Treatment Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Renal Anemia Treatment Sales by Type (2016-2021e) & (MT)
Table 101. Middle East & Africa Renal Anemia Treatment Sales by Type (2021-2026) & (MT)
Table 102. Middle East & Africa Renal Anemia Treatment Sales by Application (2016-2021e) & (MT)
Table 103. Middle East & Africa Renal Anemia Treatment Sales by Application (2021-2026) & (MT)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Renal Anemia Treatment Typical Distributors
Table 107. Renal Anemia Treatment Typical Customers
List of Figures
Figure 1. Renal Anemia Treatment Picture
Figure 2. Global Renal Anemia Treatment Sales Market Share by Type in 2020
Figure 3. Iron Supplements
Figure 4. Erythrocyte Stimulating Agents
Figure 5. Global Renal Anemia Treatment Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Research Institute
Figure 9. Other
Figure 10. Global Renal Anemia Treatment Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 11. Global Renal Anemia Treatment Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Renal Anemia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Renal Anemia Treatment Sales (2016-2026) & (MT)
Figure 32. Global Renal Anemia Treatment Production Capacity (2016-2026) & (MT)
Figure 33. Global Renal Anemia Treatment Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Renal Anemia Treatment Market Drivers
Figure 35. Renal Anemia Treatment Market Restraints
Figure 36. Renal Anemia Treatment Market Trends
Figure 37. Global Renal Anemia Treatment Sales Market Share by Manufacturer in 2020
Figure 38. Global Renal Anemia Treatment Revenue Market Share by Manufacturer in 2020
Figure 39. Renal Anemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Renal Anemia Treatment Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Renal Anemia Treatment Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Renal Anemia Treatment Sales Market Share by Region (2016-2026)
Figure 43. Global Renal Anemia Treatment Revenue Market Share by Region (2016-2026)
Figure 44. North America Renal Anemia Treatment Revenue (2016-2026) & (USD Million)
Figure 45. Europe Renal Anemia Treatment Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Renal Anemia Treatment Revenue (2016-2026) & (USD Million)
Figure 47. South America Renal Anemia Treatment Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Renal Anemia Treatment Revenue (2016-2026) & (USD Million)
Figure 49. Global Renal Anemia Treatment Sales Market Share by Type (2016-2026)
Figure 50. Global Renal Anemia Treatment Revenue Market Share by Type (2016-2026)
Figure 51. Global Renal Anemia Treatment Price by Type (2016-2026) & (USD/MT)
Figure 52. Global Renal Anemia Treatment Sales Market Share by Application (2016-2026)
Figure 53. Global Renal Anemia Treatment Revenue Market Share by Application (2016-2026)
Figure 54. Global Renal Anemia Treatment Price by Application (2016-2026) & (USD/MT)
Figure 55. North America Renal Anemia Treatment Sales Market Share by Country (2016-2026)
Figure 56. North America Renal Anemia Treatment Revenue Market Share by Country (2016-2026)
Figure 57. North America Renal Anemia Treatment Sales Market Share by Type (2016-2026)
Figure 58. North America Renal Anemia Treatment Sales Market Share by Application (2016-2026)
Figure 59. Europe Renal Anemia Treatment Sales Market Share by Country (2016-2026)
Figure 60. Europe Renal Anemia Treatment Revenue Market Share by Country (2016-2026)
Figure 61. Europe Renal Anemia Treatment Sales Market Share by Type (2016-2026)
Figure 62. Europe Renal Anemia Treatment Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Renal Anemia Treatment Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Renal Anemia Treatment Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Renal Anemia Treatment Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Renal Anemia Treatment Sales Market Share by Application (2016-2026)
Figure 67. South America Renal Anemia Treatment Sales Market Share by Country (2016-2026)
Figure 68. South America Renal Anemia Treatment Revenue Market Share by Country (2016-2026)
Figure 69. South America Renal Anemia Treatment Sales Market Share by Type (2016-2026)
Figure 70. South America Renal Anemia Treatment Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Renal Anemia Treatment Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Renal Anemia Treatment Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Renal Anemia Treatment Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Renal Anemia Treatment Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
貧血治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia. Scope of the Report: This report studies the Anemia Therape…- 鎌状赤血球貧血治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Sickle-cell anemia is a disease characterized by the presence of sickle-shaped erythrocytes. Scope of the Report: This report studies the Sickle-cell Anemia Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this r…
- 世界の腎除神経療法システム市場 2021：企業別、地域別、種類・用途別 The Renal Denervation Therapy System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 肝臓がん用薬の世界市場2018-2025 Kidney/Renal Cancer Drugs are used to cure kidney cancers.The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boo…
- 腎臓拡張器の世界市場2018-2025 This study focuses on the production side and consumption side of Renal Dilator, presents the global Renal Dilator market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.In terms of production side, this report researches the Renal…